Early

Early is a technology-enabled healthcare company focused on the early detection and prevention of chronic diseases, including cancer, heart disease, and neurodegenerative conditions. The company provides a comprehensive clinical service that integrates advanced diagnostics, such as whole-body MRI, liquid biopsies (multi-cancer early detection tests), and advanced genetic screening, with personalized medical guidance. By shifting the focus from reactive treatment to proactive prevention, Early aims to identify health risks years before symptoms appear, utilizing a data-driven approach to extend human healthspan. Their service model combines high-end diagnostic technology with a dedicated clinical team to manage long-term preventative health strategies for members.